Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | cGMP-specific 3',5'-cyclic phosphodiesterase | ||
| Ligand | BDBM50357263 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_788276 (CHEMBL1919539) | ||
| IC50 | 0.050000±n/a nM | ||
| Citation |  Hughes, RO; Maddux, T; Joseph Rogier, D; Lu, S; Walker, JK; Jon Jacobsen, E; Rumsey, JM; Zheng, Y; Macinnes, A; Bond, BR; Han, S Investigation of the pyrazinones as PDE5 inhibitors: evaluation of regioisomeric projections into the solvent region. Bioorg Med Chem Lett21:6348-52 (2011) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| cGMP-specific 3',5'-cyclic phosphodiesterase | |||
| Name: | cGMP-specific 3',5'-cyclic phosphodiesterase | ||
| Synonyms: | 3',5'-cyclic phosphodiesterase | CGB-PDE | PDE5 | PDE5A | PDE5A_HUMAN | Phosphodiesterase 2 and 5 (PDE2 and PDE5) | Phosphodiesterase 5 (PDE5) | Phosphodiesterase 5A | Phosphodiesterase 5A (PDE5A) | cGMP-binding cGMP-specific phosphodiesterase | cGMP-specific 3',5'-cyclic phosphodiesterase | ||
| Type: | Protein | ||
| Mol. Mass.: | 99975.83 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | O76074 | ||
| Residue: | 875 | ||
| Sequence: |
| ||
| BDBM50357263 | |||
| n/a | |||
| Name | BDBM50357263 | ||
| Synonyms: | CHEMBL1916293 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C24H31N5O4 | ||
| Mol. Mass. | 453.534 | ||
| SMILES | CCCOCCn1c2cc(ncc2c(NC2CCC(O)CC2)nc1=O)-c1ccc(OC)nc1 |(28.17,-7.71,;26.83,-8.48,;25.5,-7.71,;24.17,-8.48,;24.17,-10.02,;22.83,-10.79,;22.83,-12.33,;24.16,-13.11,;25.48,-12.34,;26.81,-13.1,;26.82,-14.65,;25.49,-15.41,;24.16,-14.65,;22.83,-15.41,;22.83,-16.95,;21.5,-17.72,;20.17,-16.95,;18.84,-17.71,;18.84,-19.25,;17.5,-20.02,;20.17,-20.02,;21.51,-19.26,;21.5,-14.65,;21.5,-13.11,;20.17,-12.34,;28.14,-12.33,;28.13,-10.79,;29.46,-10.01,;30.8,-10.78,;32.13,-10,;33.47,-10.77,;30.81,-12.32,;29.48,-13.1,)| | ||
| Structure | 
| ||